Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Stimulating reporting of adverse drug reactions by using a fee.

Feely J, Moriarty S, O'Connor P.

BMJ. 1990 Jan 6;300(6716):22-3. No abstract available.

2.

Pharmacovigilance for evaluating adverse drug reactions: value, organization, and methods.

Montastruc JL, Sommet A, Lacroix I, Olivier P, Durrieu G, Damase-Michel C, Lapeyre-Mestre M, Bagheri H.

Joint Bone Spine. 2006 Dec;73(6):629-32. Epub 2006 Oct 12. Review. No abstract available.

PMID:
17110152
3.

International monitoring for adverse drug reactions of long latency.

Fletcher AP, Griffin JP.

Adverse Drug React Toxicol Rev. 1991 Winter;10(4):209-30. Review. No abstract available.

PMID:
1793771
4.

Patients' role in reporting adverse drug reactions.

van Grootheest K, de Jong-van den Berg L.

Expert Opin Drug Saf. 2004 Jul;3(4):363-8. Review.

PMID:
15268652
5.

Monitoring adverse drug reactions in the postmarketing phase.

Hoigné R, Hottinger S.

Pharm Acta Helv. 1988;63(1):2-12. Review. No abstract available.

PMID:
3283774
6.

Adverse drug reactions: a review of relevant factors.

Ajayi FO, Sun H, Perry J.

J Clin Pharmacol. 2000 Oct;40(10):1093-101. Review.

PMID:
11028248
7.

Use of an algorithm to evaluate published reports of adverse drug reactions.

Case B, Oszko MA.

Am J Hosp Pharm. 1991 Jan;48(1):121-2. Review. No abstract available.

PMID:
2000870
8.

Evaluation of adverse treatment effects in controlled trials.

Lièvre M.

Joint Bone Spine. 2006 Dec;73(6):624-6. Epub 2006 Oct 11. Review. No abstract available.

PMID:
17113807
9.

Adverse drug reactions and the elderly.

Ray WA, Griffin MR, Shorr RI.

Health Aff (Millwood). 1990 Fall;9(3):114-22. Review. No abstract available.

PMID:
2227772
10.

[Drug-eruptions].

Thielen AM, Toutous-Trellu L, Desmeules J.

Rev Med Suisse. 2008 Jul 16;4(165):1671-5. Review. French.

PMID:
18767294
11.

Review of Canadian pharmacist involvement in adverse drug reaction reporting.

Taras-Zasowski KM, Einarson TR.

Can J Hosp Pharm. 1989 Jun;42(3):105-8, 133. Review.

PMID:
10318271
12.

[Drug surveillance and adverse reactions to drugs. The literature and importance of historical data].

Mariani L, Minora T, Ventresca GP.

Clin Ter. 1996 Dec;147(12):653-72. Review. Italian.

PMID:
9296925
13.

Epidemiologic assessment of adverse drug effects.

Stern RS.

Semin Dermatol. 1989 Sep;8(3):136-40. Review. No abstract available.

PMID:
2701270
14.

Decision support methods for the detection of adverse events in post-marketing data.

Hauben M, Bate A.

Drug Discov Today. 2009 Apr;14(7-8):343-57. doi: 10.1016/j.drudis.2008.12.012. Epub 2009 Jan 31. Review.

PMID:
19187799
15.

The diagnosis of adverse medical events associated with drug treatment.

Stephens MD.

Adverse Drug React Acute Poisoning Rev. 1987 Spring;6(1):1-35. Review. No abstract available.

PMID:
3303863

Supplemental Content

Support Center